{"version":"1.0","provider_name":"The Medical Xchange","provider_url":"https:\/\/themedicalxchange.com\/en\/","title":"NRTIs: Sorting Risk Relationships in Aging HIV Patients - The Medical Xchange","type":"rich","width":600,"height":338,"html":"<blockquote class=\"wp-embedded-content\" data-secret=\"rakPs0kmtK\"><a href=\"https:\/\/themedicalxchange.com\/en\/2011\/07\/17\/6th-ias-conference-on-hiv-pathogenesis-treatment-2\/\">NRTIs: Sorting Risk Relationships in Aging HIV Patients<\/a><\/blockquote><iframe sandbox=\"allow-scripts\" security=\"restricted\" src=\"https:\/\/themedicalxchange.com\/en\/2011\/07\/17\/6th-ias-conference-on-hiv-pathogenesis-treatment-2\/embed\/#?secret=rakPs0kmtK\" width=\"600\" height=\"338\" title=\"&#8220;NRTIs: Sorting Risk Relationships in Aging HIV Patients&#8221; &#8212; The Medical Xchange\" data-secret=\"rakPs0kmtK\" frameborder=\"0\" marginwidth=\"0\" marginheight=\"0\" scrolling=\"no\" class=\"wp-embedded-content\"><\/iframe><script type=\"text\/javascript\">\n\/* <![CDATA[ *\/\n\/*! This file is auto-generated *\/\n!function(d,l){\"use strict\";l.querySelector&&d.addEventListener&&\"undefined\"!=typeof URL&&(d.wp=d.wp||{},d.wp.receiveEmbedMessage||(d.wp.receiveEmbedMessage=function(e){var t=e.data;if((t||t.secret||t.message||t.value)&&!\/[^a-zA-Z0-9]\/.test(t.secret)){for(var s,r,n,a=l.querySelectorAll('iframe[data-secret=\"'+t.secret+'\"]'),o=l.querySelectorAll('blockquote[data-secret=\"'+t.secret+'\"]'),c=new RegExp(\"^https?:$\",\"i\"),i=0;i<o.length;i++)o[i].style.display=\"none\";for(i=0;i<a.length;i++)s=a[i],e.source===s.contentWindow&&(s.removeAttribute(\"style\"),\"height\"===t.message?(1e3<(r=parseInt(t.value,10))?r=1e3:~~r<200&&(r=200),s.height=r):\"link\"===t.message&&(r=new URL(s.getAttribute(\"src\")),n=new URL(t.value),c.test(n.protocol))&&n.host===r.host&&l.activeElement===s&&(d.top.location.href=t.value))}},d.addEventListener(\"message\",d.wp.receiveEmbedMessage,!1),l.addEventListener(\"DOMContentLoaded\",function(){for(var e,t,s=l.querySelectorAll(\"iframe.wp-embedded-content\"),r=0;r<s.length;r++)(t=(e=s[r]).getAttribute(\"data-secret\"))||(t=Math.random().toString(36).substring(2,12),e.src+=\"#?secret=\"+t,e.setAttribute(\"data-secret\",t)),e.contentWindow.postMessage({message:\"ready\",secret:t},\"*\")},!1)))}(window,document);\n\/\/# sourceURL=https:\/\/themedicalxchange.com\/wp-includes\/js\/wp-embed.min.js\n\/* ]]> *\/\n<\/script>\n","thumbnail_url":"https:\/\/themedicalxchange.com\/wp-content\/uploads\/2011\/07\/IAS_2318_Figure_1.JPG","thumbnail_width":960,"thumbnail_height":720,"description":"Rome - In most industrialized countries, including Canada, the phenomenon of accelerated aging is now widely considered the most significant issue for prolonging the lifespan of patients with human immunodeficiency virus (HIV). Although the first signal of earlier-than-expected, age-related morbidity and mortality was generated several years ago by a rising rate of cardiovascular events in relatively young HIV patients, it is now clear that age-related diseases are occurring earlier across a spectrum of physiological systems, including the kidneys, the skeleton, and the central nervous system (CNS). At the IAS 2011 meeting, controlling age-related diseases was identified as an urgent clinical need in parts of the world where the median age of HIV patients is rising. Despite evidence that HIV-driven inflammatory processes may be a significant source of accelerated aging, individualizing choice of pharmacologic agents to avoid exacerbating the risk of specific age-related events appears to be a critical part of strategies toward risk reduction."}